bifido

ADDRESS 23-16, Nonggongdanji-gil, Hongcheon-eup, Hongcheon-gun, Gangwon-do, Republic of Korea
TEL + 82-33-435-4962
FAX + 82-33-435-4963
Email bgn4@bifido.com
Category
ADDRESS Room 916, Blue zone,150, Jojeong-daero, Hanam-si, Gyeonggi-do, Republic of Korea
TEL + 82-31-8027-8941
FAX + 82-31-8027-8946
Email bgn4@bifido.com
Category
ADDRESS 3rd floor, 639, Seolleung-ro, Gangnam-gu, Seoul, Republic of Korea
TEL + 82-2-543-5196
FAX + 82-70-7545-0189
Email bgn4@bifido.com
Category
ADDRESS Room 1005, Building No.1, No.7001 Zhongchun Road, MinhangDistrict, 201101 Shanghai China
TEL +86-21-54718163
Email bgn4@bifido.com
Category

INTEGRATED PLATFORM

EXPRESS-PLATFORM

Integrated platform for industrialization of probiotics
and pharmabiotics

Integrated
platform

From the selection of pharmabiotics candidates to the production of finished products with various formulations, we have our own R&D and industrialization platform and we are expecting to make mutual profits through Express Platform-based collaboration.

01

Establishment of
strain bank

  • Human originated strains
  • Commercial strains
  • Type strains
  • Edible resource originated strains
02

Basic activity
evaluation

  • Basic bioactivity
  • Fermentation suitability
  • In vitro stability
  • Stress resistance
03

Basic evaluation for
commercialization

  • Culture suitability
  • Process suitability
  • Production suitability
04

Safety
evaluation

  • Secure genome information
  • In vitro safety assay
  • Safety in human
  • Meets global standards
05

Efficacy
evaluation

  • In vitro evaluation
  • Human clinical trials
  • Mechanism of efficacy
06

Industrialization &
Productization

  • Mass production process development
  • High concentration culture
  • Stabilization technology

Recently, Bifido started microbiome research on rheumatoid arthritis (RA), a chronic inflammatory disease. We analyzed the microbiota of RA patients and tried to find a way to treat even those who were less responsive to treatment.

top으로 이동